Highlights Eurofins Scientific SE

Equities

Market Closed - Euronext Paris Other stock markets 11:35:05 2024-05-08 EDT			After market 13:38:51
57.62 ^EUR	+1.59%		57.61	-0.02%

06:32am	Corella Resources Confirms High Purity Alumina Production	MT
04-29	CAC40: France's rating maintained = non-event	CF

Corella Resources Confirms High Purity Alumina Production	12:32am	MT
CAC40: starts the week slightly up, crosses the 8100 mark	04-29	CF
CAC40: interest rates soar, pulling back below 8100 pts	04-24	CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed	04-24
CAC40: rise to 8.150, but interest-rate tensions hinder progress	04-24	CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233	04-05	CF
CAC40: easily preserves 8,000Pts, NFP has no impact	04-05	CF
CAC40: ends the day balanced after a salvo of statistics	04-04	CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith	04-04	CF
EUROFINS SCIENTIFIC : Berenberg raises its price target	04-04	CF
CAC40: up slightly after PMI figures	04-04	CF
Eurofins Scientific to Purchase US-based Ascend Clinical	04-03	MT
Eurofins completes acquisition of Ascend Clinical	04-03	CF
Eurofins Scientific SE acquired Ascend Clinical, LLC.	04-02	CI
CAC40: ends with a balanced performance, helped by the banking sector	03-28	CF
CAC40: all-time high, tackles 8250 resistance level	03-28	CF
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray	03-11	MT
EUROFINS SCIENTIFIC : Lackluster FCF and dividend cut weigh on the share price	02-28
Eurofins: Adjusted EBITDA down 10% by 2023	02-27	CF
Eurofins Scientific SE Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI

No results for this search

EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed

April 24, 2024 at 11:50 am